BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10619467)

  • 21. Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism.
    Invernizzi R; Pozzi L; Garattini S; Samanin R
    Neuropharmacology; 1992 Mar; 31(3):221-7. PubMed ID: 1630590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
    Luthman J; Brodin E; Sundström E; Wiehager B
    Int J Dev Neurosci; 1990; 8(5):549-60. PubMed ID: 1704172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of centrally administrated substance P on the brain mesolimbic system activity in rats as measured by microdialysis].
    Nikolaev SV; Lebedev AA; Bychkov EP; Obliapin AV; Dambinova SA; Shabanov PD
    Ross Fiziol Zh Im I M Sechenova; 2003 Feb; 89(2):123-8. PubMed ID: 12710181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion.
    Nikolaus S; Huston JP; Schwarting RK
    Neural Plast; 1999; 6(4):77-89. PubMed ID: 10714262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripherally administered substance P affects extracellular dopamine concentrations in the neostriatum but not in the nucleus accumbens under anesthesia.
    Boix F; Mattioli R; Adams F; Huston JP; Schwarting RK
    Brain Res Bull; 1993; 31(6):655-60. PubMed ID: 7686081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis.
    Hernandez L; Hoebel BG
    Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism.
    Rivest R; Marsden CA
    Neuroscience; 1992; 47(2):341-9. PubMed ID: 1641127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
    Espino A; Llorens J; Calopa M; Bartrons R; Rodriguez-Farré E; Ambrosio S
    Brain Res; 1995 Jan; 669(1):19-25. PubMed ID: 7712161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.
    Nikolaev SV; Lebedev AA; Bychkov ER; Oblyapin AV; Dambinova SA; Shabanov PD
    Neurosci Behav Physiol; 2004 Sep; 34(7):743-6. PubMed ID: 15526431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The response of apomorphine administered into the accumbens in rats with bilateral lesions of the nucleus accumbens, induced with 6-hydroxydopamine.
    Radhakishun FS; Wolterink G; van Ree JM
    Neuropharmacology; 1988 Nov; 27(11):1111-6. PubMed ID: 3144656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine in the basal ganglia and benzodiazepine-induced sedation.
    Brose N; O'Neill RD; Boutelle MG; Fillenz M
    Neuropharmacology; 1988 Jun; 27(6):589-95. PubMed ID: 3419542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions.
    Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
    Eur J Pharmacol; 1992 Nov; 222(1):129-35. PubMed ID: 1468488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanol-tolerant and -nontolerant alcohol-preferring (P) rats.
    Murphy JM; McBride WJ; Gatto GJ; Lumeng L; Li TK
    Pharmacol Biochem Behav; 1988 Jan; 29(1):169-74. PubMed ID: 2451255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin interacts with dopaminergic neurons in rat brain.
    Reches A; Burke RE; Jiang D; Wagner HR; Fahn S
    Peptides; 1983; 4(1):43-8. PubMed ID: 6866808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.